Astellas, OSI Of U.S. Agree On Future Handling Of Hostile Takeover
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma and OSI Pharmaceuticals of the United States have negotiated a confidentiality agreement even though the two firms are in a major hostile-takeover battle